Your browser doesn't support javascript.
loading
Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19).
Aogi, Kenjiro; Watanabe, Kenichi; Kitada, Masahiro; Sangai, Takafumi; Ohtani, Shoichiro; Aruga, Tomoyuki; Kawagichi, Hidetoshi; Fujisawa, Tomomi; Maeda, Shigeto; Morimoto, Takashi; Sato, Nobuaki; Takao, Shintaro; Morita, Satoshi; Masuda, Norikazu; Toi, Masakazu; Ohno, Shinji.
Afiliación
  • Aogi K; Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Kou 160, Minamiumemoto-machi, Matsuyama, Ehime, 791-0280, Japan. aogi.kenjiro.zx@mail.hosp.go.jp.
  • Watanabe K; Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.
  • Kitada M; Breast Disease Center, Asahikawa Medical University Hospital, Asahikawa, Japan.
  • Sangai T; Department of Breast and Thyroid Surgery, Chiba University Hospital, Chiba, Japan.
  • Ohtani S; Department of Breast Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Aruga T; Department of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Kawagichi H; Department of Breast Surgery, Matsuyama Red Cross Hospital, Matsuyama, Japan.
  • Fujisawa T; Department of Breast Oncology, Gunma Prefectural Cancer Center, Ohta, Japan.
  • Maeda S; Department of Surgery, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan.
  • Morimoto T; Department of Breast Surgery, Yao Municipal Hospital, Osaka, Japan.
  • Sato N; Department of Breast Oncology, Niigata Cancer Center Hospital, Niigata, Japan.
  • Takao S; Department of Breast Surgery, Hyogo Cancer Center Hospital, Kobe, Japan.
  • Morita S; Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Masuda N; Department of Surgery, Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Toi M; Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ohno S; Breast Oncology Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Int J Clin Oncol ; 26(7): 1237, 2021 Jul.
Article en En | MEDLINE | ID: mdl-34043103
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón